Prestige Consumer Healthcare Stock Price and Value Analysis

Should you buy Prestige Consumer Healthcare stock? (NYSE:PBH). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company has stable growth.
  • This company is making money at a modest rate.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the PBH Numbers

PBH Price
(Prestige Consumer Healthcare stock price per share)
[?] PBH Fair Price
(based on intrinsic value)
[?] PBH Safety Price (based on a variable margin of safety) $28.87
[?] PE Ratio versus Sector 9% lower than other Healthcare stocks
[?] PE Ratio versus Industry 75% lower than other Unknown stocks
[?] Cash Yield 6.03%
[?] Free Cash Flow Jitter 22%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,375,067 shares shorted. With 49,297,850 shares available for purchase and an average trading volume over the past 10 trading days of 255,310, it would take at least 5.386 days for all of the short holders to cover their shorts.

Is Prestige Consumer Healthcare Stock on Sale?

We believe that Prestige Consumer Healthcare may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Prestige Consumer Healthcare looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy PBH Stock?

Does Prestige Consumer Healthcare have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.